What is somatovital therapy?
In recent years, the AIRNERGY method has developed very strongly. Thus, the original and commonly used term „AIRNERGY therapy“ was no longer sufficient for the wide range of applications. The somatovital therapy concept was developed. Somatovital therapy is a treatment method consisting of a total of three therapies.
Spirovital therapy
This most original form of our therapy is based on inhaling energized breathing air using breathing glasses. The application time, frequency and intensity can and should be individually tailored to the user.
Gastrovitaltherapy
Gastrovital therapy drunks the energized water that is produced in the bubble element and water bottle of the breathing apparatus during an application. This therapy is usually combined with spirovital therapy. But it is also possible to apply them alone. This method has proven its worth, especially in animals that, of course, in most cases cannot wear breathing glasses.
Dermovital therapy
The device („AIRNERGY Stream“) is placed on the affected, mostly aching body area and acts from the outside. The AIRNERGY stream does not require direct skin contact, so that the device can also work through the clothing.
Background
The model for somatovital therapy is photosynthesis. As with sunlight, in the presence of special sensitizers (similar to chlorophyll) atmospheric oxygen is activated at short notice. When it relapses into its basic state, energy-rich photons are sent out.
When using the AIRNERGY devices, photons are absorbed via the lungs (spirovital therapy), the stomach (gastrovital therapy) or the skin (dermovital therapy). There, they work in the cells directly on site as well as transcellular. At the same time, the photons spread throughout the body by means of hydrogen bridges over the vascular system and thus often interfere in microreactions of the body. More energy is now available to the body. Somatovital therapy and its individual forms of therapy thus support the body holistically in self-healing.[/vc_column_text][/vc_accordion_tab][vc_accordion_tab title=“⇕ Was geschieht im AIRNERGY Atemgerät?“][vc_column_text]The breathing apparatus sucks ambient air at the back of the device via an outdoor air filter, which also serves as a dust and bacteria filter, and guides it through specially coated vitalizers under the influence of light. This method is described as a chemiluminescence method and leads to the conversion of the oxygen in the air from the triplet (3O2, non-reactive) into the singlet oxygen (1O2, reactive).
The air then flows through the water-filled glass bottle for humidification. The now moistened air is again passed through AIRNERGY vitalizers. Within < 0.23 msec. oxygen in the water falls back to its basic state, the triplet state. The energy released during relapse into the triplet state is absorbed by the water molecules. This energized air is then inhaled via the breathing glasses.[/vc_column_text][/vc_accordion_tab][vc_accordion_tab title=“⇕ What happens in the AIRNERGY Stream?“][vc_column_text]For dermovitalization, a special light device – a so-called ’stream‘ – is placed on the body surface. The technology used is in principle comparable to that of the inhaler. First, oxygen is activated; in the event of an immediate relapse into the basic state, energy is released. The exact location where these processes are triggered is not yet fully clarified in the case of the stream – whether outside the body, internally or a combination of these two variants. The result is of medical importance. The energy incorporated transcutanously or released in the subcutaneous tissue can first unfold its effect directly on site (skin, vascular system). Secondly, it also appears to spread transcellularly into the wider environment (thus possible exposure to the local active and passive musculoskeletal system). Third, according to current knowledge, it is stored in hydrogen bridges and distributed ubiquitously throughout the body via the vascular system.
Approaches to take:
For dermovitalization, a special light device – a so-called ’stream‘ – is placed on the body surface. The technology used is in principle comparable to that of the inhaler described above. In the case of the stream application, two possibilities can theoretically be considered as the place of generation of the photons (externally outside the body or internally within the body). The relapse of the energized oxygen (1O2) into the basic state is also conceivable externally or internally. The exact mechanism has not yet been fully clarified. The process can be fanned out in detail so that either the externally formed singlet oxygen (1O2) externally released energy is brought directly (transcutaneously) into near-surface structures or that the externally formed singlet oxygen (1O2) enters near-surface structures and releases energy there during relapse into the basic state. As a third theoretical variant, the oxygen could be activated internally in the near-surface structures and the energy released during relapse into the basic state could be released back to the environment. The transcutaneously incorporated or released in the subcutaneous tissue energy can first unfold its effect directly on site (skin, vascular system), i.e. it influences the local endothelial, local leukocytes and macrophages. Secondly, it also appears to spread transcellularly into the wider environment and affects the local passive and active musculoskeletal system. Third, according to current knowledge, it is stored in hydrogen bridges and transported via the venous vascular system to the epiphysis with an effect on the vegetative nervous system. Questionnaire actions among those affected, opinions from therapists and reports on animal treatments with the DVT generally showed a high level of acceptance. Within a short period of time (after a few applications) improvements were already taking place, especially in the presence of chronic diseases, especially their acute, inflammatory, painful bursts, even though in some cases in some cases before, despite the massive use of conventional therapy methods.
Different oxygen therapies are also used for different diseases and indications. Somatovital therapy differs from classical oxygen therapies as follows:
- it does not cause the body an unphysiologically high concentration of oxygen
- it does not give the body more oxygen radicals (ionized oxygen/ozone)
- it does not force reactions due to substance intake
Instead, somatovital therapy has the following objectives:
- it is intended to optimize the regulatory capability of the vegetative nervous system and thus the control and regulation processes in the body
- it is intended to optimise the use of oxygen, i.e. the use of oxygen in the cells (mitochondria – energy-fired power plants)
- it is intended to defend the protective functions of cells against free radicals by increasing the body’s own protective enzymes – without the supply of foreign substances!
The three pillars of somatovital therapy
On this page you will find all important technical information on the mode of action of somatovital therapy. In the excerpts of the „Manual of Somatovital Therapy, Part II: Studies and Practical Experiences“ by Prof. Dr. Klaus Jung and Dr. Dinah Jung, recognized somatovital effects on selected organ systems, important bodily functions and common clinical conditions are described in detail, analyzed as general principles of classical natural healing methods and some visions for future developments are considered. The basis of the scientific discussions takes into account the underlying biochemical physiological relationships, illustrative case descriptions and detailed documentation of international studies.
Book excerpts
The Somatovital Principle
Sufficient presence of active oxygen is a prerequisite for all metabolic processes in higher living organisms. Its oxidative power guarantees on the one hand cellular breathing and thus an effective energy production for the construction of ATP. On the other hand, its activated forms (especially the reactive oxygen species ROS) can induce multiple damage in the organism and must therefore be kept under control. A constant, sufficient flow of oxygen from the outside air to the mitochondria must be guaranteed under all circumstances, which means a high effort of corresponding functions and structures as well as their securing: transport with the breathing air into the lungs, transition to the pulmonary capillaries and erythrocytes, binding in them to the hemoglobin, transport with the blood flow to the periphery, release from the hemoglobin , diffusion by the erythrocytes and vascular wall into the intercellular matrix, absorption into the individual cells, transition into the mitochondria and there controlled reaction with hydrogen ions for the controlled release of ATP energy on the one hand and the neutralization of excess radicals on the other. Disorders of the flow of oxygen from the outside air to the cell and the stabilization of the oxidative balance are often possible (diseases, stress, age, behavior, environment) and accordingly frequent. The result is oxygen deficiency diseases and/or an accumulation of oxygen radicals, among which – depending on the medical school – more or less many (both chronic and acute) diseases are subsumed. Accordingly, considerations of influencing the acidic material status (elimination of a deficit as well as stabilization of the oxidative balance) represented important areas of research in modern medicine up to the present day. Oxygen is the basis of any higher life. In order to be able to fully unfold its effect, however, it must be „activated“ from the „lazy“ basic state. This ‚energization‘ takes place via the short-term formation of singlet oxygen (1O2). When it relapses into the basic state, energy-rich photons are emitted, which intervene in various physiological microreactions after entering the body or emission there and trigger the desired reactions. Under ’natural‘ conditions, the activation of oxygen from the ambient air via an energy supply by sunlight takes place in the presence of special sensitizers (e.g. chlorophyll in green plants). In recent decades, a method has been successfully developed to artificially imitate this process (European patented, international insurance number WO 2002/ 026621). The invention relates to a device for the production of singletoxygen (1O2) as well as to a method for producing a dye coated surface for such a device. This consists of a chamber having two boundary surfaces, one of which is translucent, while the other – adjacent to it – is coated with a dye that is excitable by light radiation. The light source is light-emitting diodes, wherein the translucent surface filters out a certain part of the radiation, resulting in residual radiation with a special frequency spectrum. On the dye surface excited by the light radiation from the light diodes, there are exiton shocks against the oxygen molecules of the air passed through the chamber, wherein the electrons from the atomic nuclei react with jumps to the next higher incompletely occupied electron orbits (orbitals), resulting in a singlet oxygen state (1O2). After a short time, this falls back into the basic state and emits photon energy. This energy either enters the body via the mucous membrane (in spirovitalization via the alveolar mucosa, in gastrovitalization via the mucous membrane of the gastrointestinal canal), or it penetrates directly into the layers under the skin (dermovitalization). From there, the energy spreads directly transcellularly or it contributes to the increased formation of hydrogen bridges, which in the case of spirovitalization reach all body cells ubiquitously via breathing, lymph and vascular system.
Spirovital therapy SVT (energy supply via breathing)
In the practice of spirovital therapy, a special inhaler sucks in ambient air via a filter (against dust, germs) and passes it under the influence of light of defined wavelength past vitalizers with the effect that the in-air triplet oxygen (3O2) is transferred to singletoxygen (1O2) (energy supply for the process of chemiosmosis). The ‚excited‘ air then flows through a glass bottle filled with water for humidification and is then passed again by the coated dye surface. The energy released during relapse into the basic state is absorbed by water molecules (hydrogen bridge formation). The water vapor-saturated air flows at approx. 4 l/min through a stainless steel adapter to which a breathing goggle is connected. The breathing air, enriched with photons via hydrogen bridges, can thus ultimately be inhaled and transported to the lungs, where the photons enter the blood and from there into the mitochondria, where they unfold their effect. An evaluation of patient information on the effectiveness of spirovitalization revealed their successful use in diseases of the nervous system, respiratory system, cardiovascular system, musculoskeletal system, hormonal system, metabolic diseases, pain, eye diseases and immunodeficiency. In addition, the energy status (performance, activity, resilience, strength, motivation), well-being (sleep quality, mood, breathing, digestion, pain, immune position), regeneration (deepening, slowing down, relaxation, pulse calming) as well as the sensory system (smell, vision, skin, dizziness) were positively influenced. This assessment was shared in a separate survey by the therapists in charge.
Gastrovitaltherapy GVT (energy supply via the gastrointestinal channel)
Gastrovitaltherapy is made possible by the same (inhalation) device, which is also used for spirovital therapy. For them, the technical procedure was described by the „excited“ air being carried through a glass bottle filled with water for humidification. The energy released during relapse into the basic state is absorbed at this moment by water molecules (hydrogen bridge formation). This water can be drunk during or after inhalation additionally or without the use of spirovital therapy. The incorporation of the photon energy takes place in the area of the gastrointestinal canal (absorption mainly in the small and large intestine). As with dermovital therapy, it can develop directly on site (mucous membrane, vascular system), i.e. influence on the local endothelial, local leukocytes and macrophages. Secondly, it also appears to spread transcellularly into the wider environment and affects the local environment (glands, lymphatic tissue, liver, pancreas). Third, according to current knowledge, it is transported in the form of hydrogen bridges via the venous vascular system and via lymphatic pathways to the wider environment with an effect on the vegetative nervous system.
Dermovital therapy DVT (energy supply via the skin)
For dermovitalization, a special light device – a so-called ’stream‘ – is placed on the body surface. The technology used is in principle comparable to that of the inhaler described above. In the case of the stream application, two possibilities can theoretically be considered as the place of generation of the photons (externally outside the body or internally within the body). The relapse of the energized oxygen (1O2) into the basic state is also conceivable externally or internally. The exact mechanism has not yet been fully clarified. The process can be fanned out in detail so that either the externally formed singlet oxygen (1O2) externally released energy is brought directly (transcutaneously) into near-surface structures or that the externally formed singletoxygen (1O2) enters near-surface structures and releases energy there during relapse into the basic state. As a third theoretical variant, the oxygen could be activated internally in the near-surface structures and the energy released during relapse into the basic state could be released back to the environment. The transcutaneously incorporated or released in the subcutaneous tissue energy can first unfold its effect directly on site (skin, vascular system), i.e. it influences the local endothelial, local leukocytes and macrophages. Secondly, it also appears to spread transcellularly into the wider environment and affects the local passive and active musculoskeletal system. Third, according to current knowledge, it is stored in hydrogen bridges and transported via the venous vascular system to the epiphysis with an effect on the vegetative nervous system. Questionnaire actions among those affected, opinions from therapists and reports on animal treatments with the DVT generally showed a high level of acceptance. Within a short period of time (after a few applications) improvements were already expected, especially in the presence of chronic diseases, especially their acute, inflammatory, painful bursts, even though in some cases in some cases, despite the massive use of conventional therapy methods, no or only minor improvements had occurred – neither objectively nor subjectively. The most cited successes related equally to functional and organic ailments, organ-related to the musculoskeletal system, immune system, respiratory organs and teeth, diagnosis-related to arthrosis, joints, inflammation, injuries, bronchitide, NNHaf infections, tinnitus and toothache, postoperative and periodontosis-related. The DVT effect increased in acute problems, especially with the simultaneous presence of pain. In summary, dermovital therapy seems to be mainly locally skin and mucous membranes as well as nearby structures (muscle tissue, joints, NNH, vascular endothelium) and (via the vascular system) vegetative centers (epiphysis), on the one hand through an increased release of oxygen from the erythrocytes, on the other hand via their better utilization in the power plants of the cell (mitochondria), but above all via the regulation of the oxygen activation that determines cell metabolism or by disactivation of reactive oxygen species ROS.
